SAB Biotherapeutics, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 7 DEF 14A documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-25-192856 | Aug 29, 2025 | Sep 26, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-080361 | Jun 2, 2025 | Jul 17, 2025 |
| DEF 14A | DEF 14A | 0000950170-24-066767 | May 30, 2024 | May 22, 2024 |
| DEF 14A | DEF 14A | 0000950170-23-070950 | Dec 18, 2023 | — |
| DEF 14A | DEF 14A | 0000950170-23-056434 | Oct 30, 2023 | — |
| DEF 14A | FORM DEF 14A | 0001437749-23-015192 | May 19, 2023 | Jun 29, 2023 |
| DEF 14A | DEF 14A | 0000950170-22-010672 | May 25, 2022 | Jul 6, 2022 |